Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune EvasionBIOLOGY-BASELIF3.52024-04-2810OAAI
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor ResistanceCLINICAL CANCER RESEARCHIF10.22023-07-287PRE
LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6MOLECULAR IMMUNOLOGYIF32023-05-012OAAI
An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patientsCANCER RESEARCHIF16.62023-04-040PRE
Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine Loaded Nanogels (vol 21, pg 2473, 2020)BIOMACROMOLECULESIF5.42021-02-120OAAI
Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine-Loaded NanogelsBIOMACROMOLECULESIF5.42020-05-0816OAAI
CD28 Signaling Drives Notch Ligand Expression on CD4 T CellsFRONTIERS IN IMMUNOLOGYIF5.92020-05-0712OAAI